We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RS icon
551
Reliance Steel & Aluminium
RS
$21.1B
$1.17M 0.01%
4,047
-134
-3% -$38.4K
VTRS icon
552
Viatris
VTRS
$20.9B
$1.17M 0.01%
100,806
-8,489
-8% -$97.9K
RVTY icon
553
Revvity
RVTY
$12.4B
$1.14M 0.01%
8,961
+839
+10% +$98.7K
HEI.A icon
554
HEICO Corp Class A
HEI.A
$36.4B
$1.12M 0.01%
5,502
+532
+11% +$101K
EQH icon
555
Equitable Holdings
EQH
$13.5B
$1.12M 0.01%
26,666
-104
-0.4% -$4.27K
RBLX icon
556
Roblox
RBLX
$35.3B
$1.11M 0.01%
+24,997
New +$1.04M
DG icon
557
Dollar General
DG
$27.8B
$1.11M 0.01%
13,067
-517
-4% -$56.7K
PINS icon
558
Pinterest
PINS
$13.6B
$1.09M 0.01%
33,670
-2,247
-6% -$76.4K
BRBR icon
559
BellRing Brands
BRBR
$1.55B
$1.07M 0.01%
+17,688
New +$981K
BFAM icon
560
Bright Horizons
BFAM
$4.26B
$1.07M 0.01%
7,615
CINF icon
561
Cincinnati Financial
CINF
$27.7B
$1.04M 0.01%
7,652
+1,036
+16% +$134K
HRL icon
562
Hormel Foods
HRL
$14B
$1.03M 0.01%
32,474
+3,135
+11% +$99.5K
BURL icon
563
Burlington
BURL
$23.3B
$1.03M 0.01%
3,892
DRI icon
564
Darden Restaurants
DRI
$23.7B
$1.02M 0.01%
6,233
HON icon
565
Honeywell
HON
$77.7B
$1M 0.01%
5,152
-30
-0.6% -$5.82K
MKL icon
566
Markel Group
MKL
$25.2B
$1M 0.01%
639
-64
-9% -$100K
INVH icon
567
Invitation Homes
INVH
$17.9B
$993K 0.01%
28,162
-36,897
-57% -$1.32M
SWKS icon
568
Skyworks Solutions
SWKS
$8.89B
$967K 0.01%
9,793
DOW icon
569
Dow Inc
DOW
$21.5B
$967K 0.01%
17,697
KEY icon
570
KeyCorp
KEY
$24.2B
$949K 0.01%
56,637
+6,906
+14% +$110K
PARA
571
DELISTED
Paramount Global Class B
PARA
$923K 0.01%
+86,961
New +$946K
WBA
572
DELISTED
Walgreens Boots Alliance
WBA
$918K 0.01%
102,487
+8,696
+9% +$89.5K
GS icon
573
Goldman Sachs
GS
$301B
$904K 0.01%
1,825
DKNG icon
574
DraftKings
DKNG
$12.2B
$902K 0.01%
23,008
+3,165
+16% +$114K
TAP icon
575
Molson Coors Class B
TAP
$7.96B
$890K 0.01%
15,482
+2,516
+19% +$135K

Similar funds

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.